Private Wealth Management Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Private Wealth Management Group, LLC
- $363 Billion
- Q3 2025
A detailed history of Private Wealth Management Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 58 shares of REGN stock, worth $40,223. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58
Previous 59
1.69%
Holding current value
$40,223
Previous $31 Million
5.28%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
86.5MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...